Johns Hopkins Center for Psychedelic & Consciousness Research

09/01/2026

Johns Hopkins CPCR is hosting a satellite event for SfN 2026: Advancing Cross-Species Research in Psychedelic Neurosciences.

Join us for an in-depth exploration of translation methods in psychedelic neuroscience, with a special focus this year on non-human primate research. The program features keynote talks, panel discussions, and a networking poster session with cocktails and appetizers. Spots are limited and registration is first-come, first-served.

Friday, November 13, 2026 · 9:00 a.m. – 7:00 p.m.
Marriott Marquis Washington, DC

Learn more at https://www.eventbrite.com/e/advancing-cross-species-research-in-psychedelic-neurosciences-tickets-1997980277795?aff=oddtdtcreator

08/21/2026

This week, NPR featured novel data on the Oregon psilocybin services program. Associate Center Director, Dr. Albert Garcia-Romeu, weighed in on the newly published safety and mental health outcomes.

See the digital story here:

Oregon was the first state to establish a legalized and regulated psilocybin industry. Since then, thousands have tried magic mushrooms. Here is the latest data from the state's real-life experiment.

08/12/2026

Dr. Azin Bekhrad, co-founder and psychiatrist at the Johns Hopkins Clinic for Post-Psychedelic Difficulties, spoke with Scientific American on the first year of the clinic. As the first clinic in the US to specifically treat and study rare adverse effects from psychedelic use, it provides a network of providers to better understand and address these effects:

As psychedelic therapies expand, new clinics treat uncommon long-term harms

08/06/2026

We are seeking healthy individuals to take part in a Johns Hopkins research study. The study will look at the effects of psilocybin, a psychedelic drug, with pindolol (a medication that blocks a serotonin receptor). The study aims to understand the mechanisms in the brain responsible for the changes in perception induced by psilocybin. Participation will involve two dosing sessions at the Johns Hopkins Bayview campus.

Contact us at [email protected] for more information or apply at https://jhmi.co1.qualtrics.com/jfe/form/SV_2mjwBMF8bblfqku?Source=FBPost_Aug26

Postdoc Contact Information: Zarmeen Zahid, Ph.D., [email protected]
Principal Investigator: Sandeep Nayak, M.D.
Protocol: IRB00478908

08/04/2026

What should psychedelic science take - and not take - from other disciplines? Join us in celebrating the book launch of The Oxford Handbook of Psychedelic, Religious, Spiritual, and Mystical Experiences on Wed, Aug 5th from 10am-2pm ET. Attend in-person in Washington DC or virtually on Zoom.

07/28/2026

Dr. David Yaden shares insights and safety considerations for Oregon’s psilocybin services program with the Oregon Capital Chronicle:

Some of the top reasons people use Oregon's program include health and wellness, changes in perspective and "expanded concsiousness."

07/27/2026

Do you live with chronic low back pain and depression?
You’re not alone. Our research team at Johns Hopkins is studying whether psilocybin may help with pain and mood. If you’d like to learn more or see if you qualify, visit the link below. hopkinspsychedelic.org/backpain

07/14/2026

Can Psychedelics Treat Addiction? Dr. Albert Garcia-Romeu was interviewed by Dr. Jonathan Avery on Thriving with Addiction podcast, discussing his research on the effects of psychedelics on addiction: https://podcasts.apple.com/us/podcast/can-psychedelics-treat-addiction-with-dr-albert-garcia/id1865128832?i=1000776704132

Podcast · Dr. Jonathan Avery · Thriving with Addiction is a podcast about addiction, recovery, and mental health hosted by addiction psychiatrist Dr. Jonathan Avery. Through conversations with leading experts, people in recovery, families affected by addiction, and clinicians on the front lines, t...

07/07/2026

The CPCR is seeking a full-time Clinical Program Coordinator to join our team and support clinical trials and studies in the field of psychedelic science.

Learn more and apply here: https://hiring.jhu.edu/careers/job/1133914225625

07/02/2026

We are seeking healthy individuals to take part in a Johns Hopkins research study. The study will look at the effects of psilocybin, a psychedelic drug, with pindolol (a medication that blocks a serotonin receptor). The study aims to understand the mechanisms in the brain responsible for the changes in perception induced by psilocybin. Participation will involve two dosing sessions at the Johns Hopkins Bayview campus.

Contact us at [email protected] for more information or apply at https://jhmi.co1.qualtrics.com/jfe/form/SV_2mjwBMF8bblfqku?Source=FBPost

Postdoc Contact Information: Zarmeen Zahid, Ph.D., [email protected]
Principal Investigator: Sandeep Nayak, M.D.
Protocol: IRB00478908